...Health Initiative (WHI) study, sponsored the National Institutes of Health.

The landmark WHI study has raised concern about the risks associated with the use of estrogen and estrogen with progestin products, including increased risks for cardiovascular disease and breast cancer.

One arm of the WHI study found that after one year of treatment with estrogen with progestin, for every 10,000 women, there may be seven more cases of heart disease, eight more strokes, eight more instances of blood clots in the lungs, 13 more cases of blood clots in the limbs, and eight more cases of breast cancer. This part of the study was stopped in July 2002 after five years because the risks from taking the drug exceeded the benefits of reduced instances of colon cancer and bone fracture.

The WHI study included 16,000...

NOTE: All illustrations and photos have been removed from this article.



More articles from FDA Consumer
Mission: promoting, protecting the public health FDA Commissioner Mark..., March 01, 2003
User fees and medical device reviews., March 01, 2003
Breathing better: action plans keep asthma in check., March 01, 2003
An update on smallpox., March 01, 2003
FDA science: protecting America's health., March 01, 2003

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.